AbbVie Inc. Estimated Litigation Liability
AbbVie Inc. (ABBV) had Estimated Litigation Liability of $1.70 billion as of 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Balance Sheet › Liabilities
us-gaap:LitigationReserve · last filed 2026-08-03
- 2026-06-30: Estimated Litigation Liability $1.70B.
- 2026-03-31: Estimated Litigation Liability $1.70B.
- 2025-12-31: Estimated Litigation Liability $1.60B.
- 2025-09-30: Estimated Litigation Liability $1.50B.
| Period end | Estimated Litigation Liability |
|---|---|
| 2026-06-30 | $1.70B 10-Q · filed 2026-08-03 |
| 2026-03-31 | $1.70B 10-Q · filed 2026-05-08 |
| 2025-12-31 | $1.60B 10-Q · filed 2026-08-03 |
| 2025-09-30 | $1.50B 10-Q · filed 2025-11-04 |
| 2025-06-30 | $1.80B 10-Q · filed 2025-08-04 |
| 2025-03-31 | $1.80B 10-Q · filed 2025-05-09 |
| 2024-12-31 | $2.50B 10-K · filed 2026-02-20 |
| 2024-09-30 | $2.40B 10-Q · filed 2024-11-04 |
| 2023-12-31 | $2.00B 10-K · filed 2025-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |